Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15763603rdf:typepubmed:Citationlld:pubmed
pubmed-article:15763603lifeskim:mentionsumls-concept:C0029235lld:lifeskim
pubmed-article:15763603lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15763603lifeskim:mentionsumls-concept:C0332325lld:lifeskim
pubmed-article:15763603lifeskim:mentionsumls-concept:C1136254lld:lifeskim
pubmed-article:15763603lifeskim:mentionsumls-concept:C1260298lld:lifeskim
pubmed-article:15763603lifeskim:mentionsumls-concept:C1517586lld:lifeskim
pubmed-article:15763603lifeskim:mentionsumls-concept:C0972266lld:lifeskim
pubmed-article:15763603pubmed:issue1lld:pubmed
pubmed-article:15763603pubmed:dateCreated2005-3-14lld:pubmed
pubmed-article:15763603pubmed:abstractTextBacterial resistance to currently available antimicrobials is an increasing concern, particularly among various gram-positive organisms such as drug-resistant pneumococci, methicillin-resistant staphylococci, and drug-resistant enterococci. Tigecycline is an investigational glycylcycline antibiotic that shows promising activity against these resistant gram-positive organisms.lld:pubmed
pubmed-article:15763603pubmed:languageenglld:pubmed
pubmed-article:15763603pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15763603pubmed:citationSubsetIMlld:pubmed
pubmed-article:15763603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15763603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15763603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15763603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15763603pubmed:statusMEDLINElld:pubmed
pubmed-article:15763603pubmed:monthJanlld:pubmed
pubmed-article:15763603pubmed:issn0149-2918lld:pubmed
pubmed-article:15763603pubmed:authorpubmed-author:GarrisonMark...lld:pubmed
pubmed-article:15763603pubmed:authorpubmed-author:SetterStephen...lld:pubmed
pubmed-article:15763603pubmed:authorpubmed-author:NeumillerJosh...lld:pubmed
pubmed-article:15763603pubmed:issnTypePrintlld:pubmed
pubmed-article:15763603pubmed:volume27lld:pubmed
pubmed-article:15763603pubmed:ownerNLMlld:pubmed
pubmed-article:15763603pubmed:authorsCompleteYlld:pubmed
pubmed-article:15763603pubmed:pagination12-22lld:pubmed
pubmed-article:15763603pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:meshHeadingpubmed-meshheading:15763603...lld:pubmed
pubmed-article:15763603pubmed:year2005lld:pubmed
pubmed-article:15763603pubmed:articleTitleTigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.lld:pubmed
pubmed-article:15763603pubmed:affiliationDepartment of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington 99210-1495, USA. garrism@wsu.edulld:pubmed
pubmed-article:15763603pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15763603pubmed:publicationTypeReviewlld:pubmed
pubmed-article:15763603pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15763603lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15763603lld:pubmed